E
Eloxx Pharmaceuticals, Inc. (ELOX)
NCM – Real Time Price. Currency in USD
12.24
-0.57 (-4.45%)
At close: Jul 29, 2026, 4:00 PM EDT
12.25
-0.35 (-2.74%)
Pre-market: Jul 30, 2026, 7:00 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
12.24
-0.57 (-4.45%)
At close: Jul 29, 2026, 4:00 PM EDT
12.25
-0.35 (-2.74%)
Pre-market: Jul 30, 2026, 7:00 AM EDT
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribosome-selective glycoside in a Phase 2 trial for the treatment of rare kidney diseases, including Alport syndrome with nonsense mutations, cystic fibrosis with nonsense mutations, and nephropathic cystinosis with nonsense mutations, as well as in a preclinical stage for the treatment of autosomal dominant polycystic kidney disease with nonsense mutations. It has collaboration with Almirall, S.A. to develop and commercialize ZKN-013, an oral ribosome modulating agent for the treatment of rare skin diseases, such as recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullosa with nonsense mutations. Eloxx Pharmaceuticals, Inc. was incorporated in 1999 and is based in Arlington, Massachusetts.
| Name | Position |
|---|---|
| Dr. Ali Hariri M.D. | Chief Medical Officer |
| Dr. Roger Clark | VP & Head of Discovery Sciences |
| Dr. Teji Singh | VP & Head of Clinical Development |
| Mr. Daniel E. Geffken M.B.A. | Interim Chief Financial Officer |
| Mr. John Woolford | VP & Head of Corporate Development |
| Mr. Sumit Aggarwal M.B.A. | President, CEO & Director |
| Date | Type | Document |
|---|---|---|
| 2026-06-04 | S-1/A | d35071ds1a.htm |
| 2026-06-01 | S-1/A | d35071ds1a.htm |
| 2026-06-01 | 8-A12B | d75472d8a12b.htm |
| 2026-05-08 | DEF 14C | d125964ddef14c.htm |
| 2026-05-07 | S-1 | d35071ds1.htm |
| 2026-05-05 | 10-Q | elox-20260331.htm |
| 2026-05-01 | 8-K | d151139d8k.htm |
| 2026-04-28 | PRE 14C | d125964dpre14c.htm |
| 2026-03-20 | DRS | filename1.htm |
| 2026-03-17 | 10-K | elox-20251231.htm |